Ansa Biotechnologies Funding & Investors
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
https://ansabio.com/Total Amount Raised: $83,419,680
Ansa Biotechnologies Funding Rounds
Series A
$68,000,000
Series A Investors
Altitude Life Science VenturesPEAK6Carbon Silicon VenturesFifty YearsCodon CapitalMubadala Capital VenturesHumboldt FundMei Z.Fiscus VenturesBlue Water Life Science FundRA Capital ManagementNorthpond VenturesHorizons VenturesSeries Unknown
$5,000,000
Series Unknown Investors
Humboldt FundHorizons VenturesMubadala Capital VenturesGrant
$994,682
Grant Investors
National Science Foundation (NSF)Seed
$7,900,000
Seed Investors
Humboldt FundY CombinatorHorizons VenturesMubadala Capital VenturesGrant
$225,000
Grant Investors
National Science Foundation (NSF)Pre Seed
$1,300,000
Pre Seed Investors
Fifty Years
Funding info provided by Diffbot.